What is Market Access
Market access is the process of helping a medical technology reach the patients and healthcare organisations that could benefit from it.
For MedTech companies, bringing an innovative medical device, diagnostic or digital health technology to market involves much more than achieving regulatory approval.
Healthcare decision makers also need to understand the technology's clinical value, economic impact, funding route and potential benefit to patients and healthcare services.
A strong market access strategy helps connect medical technology innovation with real world healthcare adoption.
What Does Market Access Mean in MedTech?
MedTech market access focuses on creating the right conditions for a medical technology to be evaluated, funded, adopted and used within a healthcare system.
It can involve understanding:
The healthcare market and unmet need
Clinical and economic evidence
Health technology assessment
Reimbursement and funding
NHS pathways and decision makers
Patient and healthcare system value
Barriers to local adoption
Stakeholder engagement
The requirements are different for every technology, healthcare pathway and NHS organisation, which is why there is rarely a single route to successful market access.
Why Is Market Access Important?
Healthcare organisations operate within limited budgets while facing increasing demand for services. As a result, demonstrating that a medical technology works may not be enough.
Decision makers may also want to understand:
Does the technology address a genuine unmet need?
What value could it offer patients?
Could it improve an existing healthcare pathway?
What impact could it have on healthcare resources?
How could it be funded or reimbursed?
What evidence is required to support adoption?
Understanding these questions early can help MedTech companies identify potential barriers before they become obstacles to adoption.
Market Access and NHS Adoption
For medical technology companies targeting the NHS, market access can be particularly complex. National approval, guidance or reimbursement does not necessarily lead to local adoption, and individual NHS organisations can have different priorities, pathways, budgets and evidence requirements. A successful NHS market access strategy therefore needs to consider both the wider healthcare landscape and the organisations responsible for implementing the technology.
This can involve understanding local patient populations, current pathways, reimbursement mechanisms, healthcare activity, decision makers and the value a technology could provide within individual NHS organisations. Knowing where your technology fits and how its value should be communicated is an important part of building an effective route into the NHS.
The Key Elements of MedTech Market Access
Although every medical technology requires a tailored strategy, several areas commonly influence successful market access.
Market Understanding
Understanding the target market, patient population, existing pathway, competing technologies and areas of unmet need can help determine where an innovation has the strongest opportunity.
Evidence and Value
Medical technology companies need evidence that communicates more than clinical performance alone. Decision makers may consider the wider impact on patients, healthcare professionals, resources and the healthcare system when assessing a new technology.
Health Economics
Health economics can help demonstrate the potential economic value of introducing a medical technology compared with current practice. The type of evidence required will depend on the technology, pathway and decision being supported.
Reimbursement and Funding
Understanding medical device reimbursement and NHS funding pathways is an important part of market access planning. A technology may offer significant clinical value, but uncertainty around how it will be funded can create a major barrier to adoption.
Stakeholder Engagement
Different stakeholders can influence the adoption of a medical technology. Identifying who those stakeholders are, what matters to them and what evidence they require can help companies communicate their value proposition more effectively.
Market Access Is More Than Regulatory Approval
Regulatory approval and market access are closely connected, but they are not the same. Regulatory approval enables a medical technology to be placed on a market.
Market access focuses on what happens next. It considers whether the technology has the evidence, value proposition, funding pathway and healthcare support required to achieve meaningful adoption. Similarly, securing reimbursement does not necessarily guarantee that a technology will be routinely used. Successful market access involves understanding and addressing the wider barriers between approval and patient access.
When Should MedTech Companies Think About Market Access?
Ideally, market access planning should begin early in the development of a medical technology. Waiting until launch can mean discovering evidence gaps, reimbursement challenges or adoption barriers when there is less opportunity to address them. Early market access planning can help ensure that development, evidence generation and commercial strategy are aligned with the requirements of the healthcare system the company ultimately wants to enter.
What Does a Market Access Strategy Include?
There is no universal market access strategy. The right approach depends on the technology, target patient population, healthcare pathway, available evidence and intended market.
A tailored MedTech market access strategy may consider areas such as:
Market analysis
Evidence requirements
Health economics
Reimbursement
NHS pathways
HTA strategy
Value proposition development
Local adoption barriers
Stakeholder engagement
Determining which of these areas matters most, and when they should be addressed, requires a detailed understanding of both the technology and the healthcare environment.
Frequently Asked Questions
What is market access in simple terms?
Market access is the process of ensuring a medical technology can be funded, adopted and used by the patients who could benefit from it. For MedTech companies, it brings together evidence, reimbursement, health economics, stakeholder engagement and adoption planning to create a clear route from innovation to real world healthcare use.
What is MedTech market access?
MedTech market access focuses specifically on medical devices, diagnostics, digital health technologies and other medical innovations. It can involve evidence, health economics, reimbursement, HTA, stakeholder engagement and adoption strategy.
Is market access the same as reimbursement?
No. Reimbursement is an important element of market access, but market access is broader and also considers evidence, value, stakeholders and barriers to adoption.
Is market access the same as regulatory approval?
No. Regulatory approval determines whether a medical technology can be placed on the market. Market access considers how it can subsequently be funded, adopted and used within healthcare.
Why is market access important for MedTech companies?
A strong market access strategy can help companies understand what healthcare decision makers require, identify barriers to adoption and build a clearer route from medical technology innovation to patient access.
Navigating Market Access for Your Medical Technology
Every medical technology faces a different route to adoption. Understanding what evidence is needed, how reimbursement works, who the relevant decision makers are and where potential barriers exist can make the difference between entering a market and achieving meaningful adoption within it. That is where specialist market access support becomes valuable.
If you are developing a medical device, diagnostic or digital health technology and need support understanding your route into the NHS, speak to our team about developing a market access strategy tailored to your technology.
